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Abstract
Background: Experiences and inflammatory mediators are fundamental in the provocation of major depressive
disorders (MDDs). We investigated the roles and mechanisms of inducible nitric oxide synthase (iNOS) in
stress-induced depression.
Methods: We used a depressive-like state mouse model induced by unpredictable chronic mild stress (UCMS).
Depressive-like behaviors were evaluated after 4 weeks of UCMS, in the presence and absence of the iNOS inhibitor
N-(3-(aminomethyl)benzyl)acetamidine (1400 W) compared with the control group. Immunohistochemistry was used
to check the loss of Nissl bodies in cerebral cortex neurons. The levels of iNOS mRNA expression in the cortex and
nitrites in the plasma were measured with real-time reverse transcription PCR (RT-PCR) and Griess reagent
respectively.
Results: Results showed that the 4-week UCMS significantly induced depressive-like behaviors, including decreased
sucrose preference in a sucrose preference test, increased duration of immobility in a forced swim test, and
decreased hole-searching time in a locomotor activity test. Meanwhile, in the locomotor activity test, UCMS had no
effect on normal locomotor activities, such as resting time, active time and total travel distance. Furthermore, the
levels of iNOS mRNA expression in the cortex and nitrites in the plasma of UCMS-exposed mice were significantly
increased compared with that of the control group. Neurons of cerebral cortex in UCMS-exposed mice were
shrunken with dark staining, together with loss of Nissl bodies. The above-mentioned stress-related depressive-like
behaviors, increase of iNOS mRNA expression in the cortex and nitrites in the plasma, and neuron damage, could be
abrogated remarkably by pretreating the mice with an iNOS inhibitor (1400 W). Moreover, neurons with abundant
Nissl bodies were significantly increased in the 1400 W+UCMS group.
Conclusions: These results support the notion that stress-related NO (derived from iNOS) may contribute to
depressive-like behaviors in a mouse model, potentially concurrent with neurodegenerative effects within the
cerebral cortex.
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Background
The challenges of modern society are largely responsible
for generating stress in human beings. Stress in turn
engenders multiple neurochemical, neurotransmitter and
hormonal changes. Studies carried out with some stress
protocols (physical, psychological or mixed) show a proin-
flammatory response in the brain and other systems,
mainly characterized by a complex release of several in-
flammatory mediators [1]. In recent years, inflammation
has been implicated in chronic psychiatric disorders. Cyto-
kines such as interleukin (IL)-1β and IL-6 are elevated in
the serum of depressed patients [2]. Therefore, stress has
been one of the most important pathogenic factors in sev-
eral neuropsychiatric diseases such as depressive disorder.
And stress exposure modifies the onset and evolution of
some neurological diseases [1]. According to a report from
the World Health Organization (WHO), depression is the
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and is predicted to be in second place by 2020 [3]. There-
fore, it is important to reveal the mechanism of depression.
However, it is still unknown that how chronic stress
induces or precipitates depression.
Nitric oxide (NO), a free gaseous signaling molecule, is
involved in the regulation of the nervous and immune sys-
tem. It has been suggested NO is involved in depression
and stress [4]. There are three genetically different iso-
forms of nitric oxide synthase (NOS) that account for NO
production: neuronal nitric oxide synthase (nNOS) being
the isoform first identified in neurons, endothelial nitric
oxide synthase (eNOS) being the isoform first identified in
endothelial cells, and inducible nitric oxide synthase
(iNOS), which can be synthesized following induction by
proinflammatory cytokines or endotoxins [5]. The NOS
enzymes are widely distributed within the mammalian
brain. NOS-positive neurons are located in the hippocam-
pus, cerebral cortex and other encephalic regions [6]. Vari-
ous studies suggest the involvement of nNOS in the
pathophysiological mechanism of depression-like behavior
in rodents [7-10]. Over the last two to three decades, the
‘inflammatory depression hypothesis’ has attracted great
attention. Chronic inflammation is often associated with
clinical depression [11-15]. Chronic stress is associated
with dysregulated immunity by overactivating the immune
system, leading to low-grade inflammation [16]. iNOS is
inflammation inducible and plays no role in the brain
under normal physiological conditions. However, under
pathological conditions, iNOS may become important.
Therefore, we chose iNOS as our focus to identify whether
and how NOS is involved in the pathogenesis of the de-
pressive behavior induced by chronic stress exposure.
Converging lines of research suggest that both functional
alterations and structural changes in the volume of the
hippocampal complex play roles in the pathophysiology of
depressive disorder [17]. And the effects of stress on the
hippocampus are clear. The hippocampus is often consid-
ered to be the classical region to assess morphological
effects related to depression. However, morphological plas-
ticity has been less intensively studied in the cortex than in
the hippocampus under stressed conditions. Furthermore,
clinical and experimental evidence suggest the cortex is
pathophysiologically related to depression. However, it is
unknown what roles the cortex plays in stress-initiated de-
pression. We selected the cortex for morphological assess-
ment in our present study to investigate its potential
importance in stress-related depression.
Considering that chronic stress can induce inflammatory
responses and depressive behaviors in animals, and iNOS
is inflammation inducible, we hypothesize that iNOS plays
a critical role in stress-related depression. If the above as-
sumption is true, the levels of iNOS and NO should be
changed in stress-exposed animals. Additionally, an
inhibitor of iNOS should block the alteration of iNOS and
NO, followed by the recovery of depressive behaviors
induced by stress exposure. The potential mechanism
underlying the antidepressant effects of iNOS inhibitor
may be neuron protection. Therefore, the present study
was performed to verify the above hypothesis in a step-by-
step manner.
Methods
Reagents
Quantscript cDNA RT kit (catalogue no. KR-103), reverse
transcriptase kit and TRIzol reagent were purchased from
Tiangen Biotech (Beijing, China). Real-time reverse tran-
scription PCR (RT-PCR) primers for iNOS (catalogue no.
M301149, M301150) and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH; catalogue no. M301155, M301156)
were all obtained from Sangon Biotech (Shanghai, China).
Total nitric oxide assay kit and iNOS inhibitor N-(3-(ami-
nomethyl)benzyl)acetamidine (1400 W) were obtained from
Beyotime Institute of Biotechnology (Jiangsu, China). Other
reagents and chemicals were obtained from Sigma Aldrich
(St. Louis, MO, USA).
Animals and chronic unpredictable mild stress model
Male, 9-week-old BALB/c mice weighing 20 to 25 g (Ani-
mal Centre, Second Military Medical University, China)
were used in this study. All procedures were approved by
the local animal care committees in accordance with
related regulations and laws. Before the onset of experi-
ments, 1 week was allowed for the mice to adapt to their
new circumstances, and another 2 weeks to adapt to the
sucrose solution. Next, the mice were split into three
groups: a non-stressed group, a UCMS exposed (stressed)
group, and a UCMS exposed+1400 W group. Non-
stressed mice were group housed under standard labora-
tory conditions (12-h light: 12-h dark cycle, lights on at
07:00 AM; temperature: 22±1°C; humidity: 52±2%) in a
separate room. Stressed mice were isolated in individual
cages. All animals received food and water ad libitum,e x -
cept for during the sucrose preference test. The UCMS
regimen was based on the procedures described by other
researchers, with minor modifications [18]. Briefly,
UCMS-exposed mice were subjected to various stressors
in a chronic, inevitable and unpredictable way according
to a random schedule for 4 weeks. The stressors were:
damp bedding for 12 h; 45° cage tilting for 14 to 18 h; con-
tinuous light on (24 h); water and food deprivation for 14
to 18 h; strong level shaking for 10 minutes; ice-cold
swimming for 5 minutes; 45°C oven for 5 minutes; con-
finement in a tube for 2 h. Random stressors (as shown in
Table 1) were applied on purpose, at random times of both
night and day, in order to be completely unpredictable. All
mice in the stress group were exposed to the same single
stressor simultaneously in 1 day. No single stressor was
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of stress, each stressor was applied two or three times.
Body weight and sucrose preference were assessed weekly.
Drug or vehicle treatments started on day 7 and were
stopped the day after the end of UCMS (day 28). 1400 W
was injected intraperitoneally at 10 mg/kg three times a
week as according to a previous report [19]. The control
group received saline solution of the same volume as that
of 1400 W.
Behavioral tests
Sucrose preference test
Anhedonia was measured by preference for a sucrose so-
lution over water, using a two-bottle free choice method
[20]: each animal was presented simultaneously with two
bottles, one containing 1% sucrose solution (w/v), the
other containing tap water. Blunted sucrose intake in this
test is proposed to reflect impaired sensitivity to reward
and model anhedonia, a core symptom of major depres-
sion [21]. Tap water and 1% sucrose solution were placed
in premeasured bottles in the cages, and fluid intake was
monitored for 1 h. Both bottles were removed and
weighed after 1 h. Mice were given access to sucrose so-
lution for 2 weeks preceding the experimental proce-
dures to adapt to this taste. Sucrose preference tests
were timetabled during the dark phase (19:00 PM to
20:00 PM) in the home cage. Mice were denied food and
water for about 20 h before each sucrose preference test.
The baseline preference test was performed before the
onset of stress, and preference tests were then conducted
weekly throughout the UCMS period. Sucrose preference
was evaluated via the sucrose uptake rate, namely, the
ratio of volume of sucrose consumption to the volume
of sucrose consumption plus tap water consumption (su-
crose preference=sucrose consumption/(sucrose con-
sumption + water consumption)×100%).
Locomotor activity test
On the subsequent day after the last sucrose preference
test, a locomotor activity test was carried out during the
night. The locomotor activity test is used to measure spon-
taneous activity in rodents. The apparatus consisted of a
dark rectangular box with a square floor, divided into small
rectangular units and holes. A single mouse was gently
placed in the center of the box for 30 s of adaptation, and
then allowed to freely explore the area for 5 minutes. All
behaviors including the number of activities, the resting
and active time, hole-searching time, and so on, were
recorded automatically by DigBehv animal behavior ana-
lysis software (Jiliang Software Technology, Shanghai,
China) during the 5 minutes. After each test, the floor was
cleaned thoroughly with 75% alcohol solution to eliminate
possible bias due to odors left by previous mice [22].
Forced swim test
The forced swim test (FST) was performed following the
locomotor activity test at night-time, conducted as
described previously [23]. Briefly, each mouse was placed
individually in a transparent cylindrical polypropylene tank
(40 cm height×30 cm diameter) containing 35 cm of water
at 25±1°C, without the possibility of escaping. Mice were
forced to swim in the water for 6 minutes. A mouse was
judged immobile when it floated in an upright position,
and could only move slowly to keep its head above water.
The duration of immobility during the final 5 minutes of
the test was recorded. This immobile posture reflects a
state of behavioral despair or helplessness [24]. Mice were
dried immediately and returned to their home cages after
the swimming test.
Sample collection
After the behavioral tests, three mice from each group were
deeply anesthetized and perfused with 4% paraformaldehyde
Table 1 Unpredictable chronic mild stress procedure
Week Monday Tuesday Wednesday Thursday Friday Saturday Sunday
First week 8:00 AM to
10:00 PM:
tilted cage
10:00 AM to
12:00 AM:
cage shaking
for 10 minutes
17:00 PM to
next day: damp
bedding
9:00 AM to
11:00 AM:
swimming at
4°C for 5 minutes
15:30 PM to
17:30 PM:
confinement in
tube for 2 h
22:00 PM to
next day:
food and
water deprivation
21:00 PM
to 22:00 PM:
sucrose preference
test
Second week 17:30 PM to
next day:
persistent
illumination
9:00 AM to
11:00 AM:
45°C oven for
5 minutes
18:00 PM to
next day:
tilted cage
13:30 PM
to 15:30 PM:
confinement in
tube for 2 h
19:00 PM to
next day: damp
bedding
20:00 PM to
next day: food
and water
deprivation
19:30 PM to
20:30 PM:
sucrose preference
test
Third week 10:30 AM to
12:30 PM:
confinement
in tube for 2 h
17:00 PM to
next day:
damp
bedding
8:00 AM to
10:00 PM:
tilted cage
19:30 PM to
next day: persistent
illumination
10:00 AM to
12:00 AM:
cage shaking
for 10 minutes
21:00 PM to
next day: food
and water
deprivation
20:00 PM to
21:00 PM: sucrose
preference test
Fourth week 19:00 PM to
21:00 PM: 45°
C oven for
5 minutes
8:00 AM to
10:00 PM:
tilted cage
13:30 PM to
15:30 PM:
confinement in
tube for 2 h
9:00 AM to
11:00 AM: cage
shaking for 10
minutes
17:30 PM to next
day: persistent
illumination
23:00 PM to
next day: food
and water deprivation
22:30 PM to
23:30 PM: sucrose
preference test
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anesthetized and killed; blood was collected and brains were
removed. Blood, anticoagulated with 1.5% EDTA was cen-
trifuged at 12,000 rpm for 10 minutes, and then the super-
natant was collected. All these samples were stored at −80°
Cf o rf u r t h e ra n a l y s i s .
RNA extraction and reverse transcription
Total RNA was extracted from the brain tissue using
TRIzol reagent. Total mRNA (1 μg) was reverse tran-
scribed using Quantscript cDNA RT Kits according to
the manufacturer’s manual. Briefly, RNA (1 μg) was pre-
treated with DNA-free DNase treatment and removal
reagents. RNA samples were incubated with a mixture
consisting of containing dNTPs, random primers, 10×
RT mix, Quant Reverse Transcriptase, a reverse tran-
scriptase and RNase-free water to a final volume of 10 μl
at 37°C for 1 h.
Real-time RT-PCR
cDNA was used for quantification of mRNA by real-time
RT-PCR. Real-time RT-PCR was performed on an Ap-
plied Rotor-Gene 3000 (Corbett Research, China)under
the following conditions: iNOS and GAPDH for 40
cycles at 94°C for 30 s, 63°C for 60 s, and 72°C for 90 s.
Relative quantitative measurements of target gene levels
were performed using the ΔΔCt method, where Ct is the
threshold concentration. GAPDH was used as endogen-
ous control to normalize gene expression data, and an
RQ value was calculated for each sample. RQ values are
presented as fold change in gene expression relative to
the control group, which was normalized to 1. The fol-
lowing oligonucleotides were used as primers: iNOS
(forward, 5'-GACTGCACAGAATGTTCCAG-3'; reverse,
5'-TGGCCAGATGTTCCTCTATT-3'), GAPDH (forward,
5'-TCCCTCAAGATTGTCAGCAA-3'; reverse, 5'-AGATC-
CACAACGGATACATT-3') [25].
Total NO production assay
Total NO production was estimated by measurement of
the accumulation of nitrite and nitrate in plasma spectro-
photometrically using the Griess reagent by Total Nitric
Oxide Assay Kit (Beyotime, Jiangsu, China). Nitrate was
measured after enzymatical conversion to nitrite by nitrate
reductase. Nitrite is the stable reactive end production of
NO. Briefly, 60 μl of each sample supernatant was mixed
with an equal volume of dilution buffer in duplicate wells
of a 96-well plate at room temperature. The mixture was
incubated with 5 μl of nicotinamide adenine dinucleotide
phosphate (NADPH), 10 μl of flavin adenine dinucleotide
(FAD) and 5 μl of nitrate reductase for 15 minutes at 37°C.
Then, 10 μl of lactate dehydrogenase (LDH) buffer and
10 μl of LDH were added in the above reaction buffer for
another 5 minutes at 37°C. Finally, 50 μlo fG r i e s sr e a g e n t
Ia n d5 0μl of Griess reagent II were mixed into all the
above wells before incubation for 10 minutes. Optical
density at 540 nm was measured with an OPTImax multi-
plate reader. Concentrations were calculated by comparing
absorptions with those of a standard curve (50, 20, 10, 5
and 2 μM sodium nitrite).
Immunohistochemistry
Nissl staining
After behavioral tests, three mice from each group were
deeply anesthetized and perfused through the left heart
ventricle with 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). The brain tissues were removed and post
fixed immediately in the same fixative solution at 4°C for
48 h. Next, the tissues were dehydrated and immersed in
paraffin, cut into 4 μm sections, mounted on slides. For
Nissl staining, the sections were hydrated in 1% toluidine
blue at 50°C for 20 minutes. After rinsing with double
distilled water, they were dehydrated and mounted with
permount. The cortex was captured and cell numbers
were quantitatively analyzed with Imaging Pro-Plus
(LEIKA DMLB).
Cell counting
To estimate the number of undamaged neurons in the
cortex after treatments, photos of immunohistochemical
slides were taken using a digital camera connected to a
microscope at 100× and 400× magnification. Neurons
with round cell bodies, visible nucleus and abundant
Nissl bodies were considered undamaged, while Nissl-
positive cells with dark staining in which the nucleus
were not discernable were considered damaged [26].
Detailed performance and measurements were as previ-
ously described [27].
Statistical analysis
For multiexperimental group analysis, data were analyzed
using a one-way analysis of variance (ANOVA), followed
by a post hoc pairwise multiple comparison using Fisher’s
least significant difference test if the interaction was signifi-
cant. The time course of sucrose preference was analyzed
by repeated measures ANOVA. Statistical significance was
determined as P<0.05. All data are presented as the
mean±SEM.
Results
To explore whether and how depressive behavior was
induced by UCMS, mice were treated with UCMS for
4w e e k si nt h ep r e s e n c ea n da b s e n c eo ft h ei N O Si n h i b i t o r
1400 W. Depressive behaviors were measured and analyzed,
and iNOS expression and neuron viability were also
assayed.
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time-dependent manner
The sucrose preference test is used to validate animal
models of depression, especially chronic mild stress
(CMS). When given a choice between sweetened solu-
tions and tap water, rodents prefer to consume swee-
tened solutions [28,29]. Anhedonia, often reflecting
depression, can be demonstrated by the reduction in
sucrose intake and sucrose preference, compared to
the baseline, or that of the control group. So the
change of sucrose preference in UCMS-treated mice
was measured and analyzed. A time course of sucrose
preference was performed. Mice were subjected to
various stressors according to a ‘random’ scheme for
4 weeks. The basal sucrose preference was performed
at the beginning of stress exposure. Next, real-time
sucrose preference was measured at each weekend to
estimate the effect of stress. Figure 1 showed that the
sucrose preference of UCMS-exposed mice decreased
in a time dependent manner, and reached the mini-
mum at the third to fourth week, as shown by a sig-
nificant treatment effect (F(1,11)=8.60, P<0.05).
Therefore, we decided to use a 4-week UCMS treatment
in subsequent experiments. The sucrose preference of
stress-exposed mice began to decrease at the end of the
second week. So the inhibitor of iNOS was administrated
at the beginning of the second week with stress exposure
to estimate the prophylactic role of iNOS inhibitor.
Increase of iNOS mRNA expression induced by UCMS was
abrogated by the iNOS inhibitor 1400 W
To examine whether UCMS could induce iNOS expres-
sion, we analyzed iNOS mRNA expression after the 4-week
UCMS. RT-PCR analysis was performed to investigate
whether UCMS induced iNOS mRNA expression in the
cortex. As shown in Figure 2, the level of iNOS mRNA
expression by 4-week UCMS was significantly enhanced
(F(2, 9)=24.61, P<0.01). Subsequently, the level of the
product of iNOS, NO in the plasma was also assayed using
Griess reagent. Figure 3 showed that the level of nitrite, the
stable end product of NO, in the plasma of UCMS-exposed
mice was significantly increased (F(2, 14)=88.30, P<0.01).
N e x t ,t h ee f f e c t so f1 4 0 0Wo nU C M S - i n d u c e di N O S
expression and NO generation were investigated. 1400 W
is the specific iNOS inhibitor exhibiting over 5000-fold or
200-fold greater selectivity for iNOS as compared with
eNOS or nNOS. Mice were treated with 1400 W as well as
U C M S .T h er e s u l t s( F i g u r e s2a n d3 )s h o w e dt h a tt h i s
increase of iNOS mRNA expression and NO production
induced by UCMS was abrogated by 1400 W (P<0.01),
comparing with that of the stress group.
Decrease of sucrose preference induced by UCMS was
modulated by the iNOS inhibitor 1400 W
To evaluate whether the iNOS pathway is involved in the
modulation of the decrease of sucrose preference induced
by UCMS, the changes in sucrose preference in UCMS-
treated mice with the presence or absence of the iNOS in-
hibitor 1400 W were measured. The result (Figure 4)
showed that the sucrose preference of UCMS-exposed
mice decreased remarkably compared to that of the con-
trol group (F(2,19)=5.67,P<0.05). Furthermore, the iNOS
inhibitor 1400 W completely abrogated this decrease
(P<0.05). There was almost no change in behavior of the
mice treated with 1400 W alone (data not shown). There-
fore, iNOS might have an effect on UCMS-induced sucrose
preference or anhedonia.
1400 W abrogated the increase of immobility time in
forced swim test by UCMS
The forced swim test (FST) is one of the most com-
monly used animal behavioral tests for antidepressant
Figure 1 Unpredictable chronic mild stress (UCMS) induced the decrease of sucrose preference in a time-dependent manner. UCMS-exposed
mice were subjected to UCMS for 4 weeks. Sucrose preference was evaluated via sucrose uptake rate, namely, ratio of volume of sucrose
consumption to volume of sucrose plus tap water consumption. Data are mean±SEM (n=7 for control; n=6 for stress).
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FST is based on the measurement of the duration
that mice and rats stay immobile. Increased immobil-
ity in the test is claimed to reflect a helpless or resig-
nation-like state. The immobility time was measured
to evaluate whether the iNOS inhibitor 1400 W was
involved in FST. After forced swimming for 6 min-
utes, the immobility time in the last 5 minutes was
recorded. As shown in Figure 5, the immobility time
of UCMS-exposed mice in the FST increased signifi-
cantly comparing with that of the control group
(F(2,26)=11.34, P<0.01). Furthermore, the iNOS in-
hibitor 1400 W completely abrogated this increase
(P<0.01). Therefore, iNOS pathway may also play a
role in the helpless state of depressive-like behavior.
1400 W abrogated the decrease of hole-searching time
but had no effect on central time and total travel distance
in locomotor activity test by UCMS
Hole-searching and central time and total travel distance,
which reflect the exploratory behavior, were recorded for
5 minutes in the locomotor activity test to evaluate
whether iNOS was involved in the modulation of ex-
ploratory behavior. As shown in Figure 6, 4 weeks of
UCMS significantly reduced the hole-searching time
(F(2,19)=5.66, P<0.01) compared with that of the control
Figure 2 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) abrogated the
increase of iNOS mRNA expression induced by unpredictable chronic mild stress (UCMS) in the cortex. UCMS-exposed mice were
subjected to various stressors for 4 weeks. Transcript of iNOS was assayed by RT-PCR in the cortex. Values are mean ± SEM (n=4 in each group).
**P <0.01 for each comparison.
Figure 3 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) abrogated the
increase of nitrite, a stable NO product. Mice were subjected to various stressors in the presence or absence of the iNOS inhibitor 1400 W for
4 weeks. Nitrite was assayed by Griess reagent. Data are mean ± SEM (n=6 for control; n=6 for stress; n=5 for stress + 1400 W).
**P <0.01 for
each comparison.
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pletely abrogated this decrease (P<0.01). However, the
iNOS inhibitor 1400 W had no effect on the increase of
central time and total travel distance induced by UCMS
(Figure 7), even though UCMS significantly increased
the central time (F(2,26)=6.37, P<0.01) and total travel
distance (F(2,26)=5.82, P<0.05). Therefore, the iNOS
pathway may have certain effects on the exploratory be-
havior during depressive-like behavior.
Locomotor activity was not modulated by UCMS and the
iNOS inhibitor 1400 W
Locomotor activity is a valid readout of sickness behav-
ior. A sick animal usually exhibits a reduction in locomotor
activity. To confirm that UCMS-induced depressive-like be-
havior was different from the sickness behavior, mice were
tested for locomotor deficits. The results showed that there
were no significant differences in locomotor activity be-
tween the UCMS-exposed mice and those in the control
group. These locomotor activities included resting time
(Figure 8A, F(2,26)=1.68) and number of activities (Figure 8B,
F(2,26)=1.70). Furthermore, the iNOS inhibitor 1400 W
had no effect on these locomotor activities compared
with that of the control group and stress group. Gen-
erally speaking, in the absence of any overt signs of
sickness behavior, UCMS induced an obvious time-
dependent increase in depressive-like behaviors, and
the iNOS inhibitor 1400 W could abrogate some of
the effects induced by UCMS.
Figure 4 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) abrogated the
decrease of sucrose preference induced by unpredictable chronic mild stress (UCMS). Mice were subjected to various stressors in the
presence or absence of the iNOS inhibitor 1400 W for 4 weeks. Sucrose preference = sucrose consumption/(sucrose consumption + water
consumption)×100%. Data are mean ± SEM (n=7 for control; n=6 for stress; n=9 for stress+1400 W).
*P <0.05 for each comparison.
Figure 5 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) abrogated the
increase of immobility time induced by unpredictable chronic mild stress (UCMS). Mice were subjected to various stressors in the presence
or absence of the iNOS inhibitor 1400 W for 4 weeks. Immobility time was recorded in the forced swim test. Data are mean ± SEM (n=10 for
control; n=10 for stress; n=9 for stress+1400 W).
**P <0.01 for each comparison.
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by UCMS
The effects of chronic stress and iNOS inhibitor pre-
treatment on cortical neurons were explored. Immu-
nohistochemical analysis for undamaged neurons by
Nissl staining was performed. As shown in Figure 9A,
B, in the control group and stress plus 1400 W
group, neurons with round cell bodies, visible nucleus
and abundant Nissl bodies were observed. However in
the stress group, Nissl-positive cells with dark staining
in which the nucleus were not discernable were obvi-
ously increased. Cell counting showed that the num-
ber of undamaged cells in the stress group was
significantly lower than that of the control group
(F(2,6)=160.11, P<0.01). Furthermore, the iNOS in-
hibitor 1400 W abrogated this decrease of undamaged
neurons (P<0.01). Namely, 1400 W pretreatment
protected the cortex neurons from damage induced
by UCMS.
Discussion
The results of the present study demonstrated that chronic
stress significantly induced depressive-like behaviors in
mice. The levels of iNOS mRNA expression in the cortex
and nitrites in the plasma of UCMS-exposed mice were
significantly increased compared with that of the control
group. The neurons of the cerebral cortex in UCMS-
exposed mice were shrunken, together with loss of Nissl
bodies. However, the stress-related depressive-like beha-
viors, the increase of iNOS mRNA expression and nitrites,
and neuron damage were remarkably abrogated by pre-
treating the mice with an iNOS inhibitor (1400 W).
The relationship between NO and depression has been
noticed clinically. Plasma nitrate concentrations, an index
Figure 6 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) abrogated the
decrease of hole-searching time induced by unpredictable chronic mild stress (UCMS). Mice were subjected to various stressors in the
presence or absence of the iNOS inhibitor 1400 W for 4 weeks. Hole-searching time was recorded in the locomotor activity test. Data are
mean±SEM (n=8 for control; n=6 for stress; n=8 for stress+1400 W).
**P <0.01 for each comparison.
Figure 7 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) had no effect on
the unpredictable chronic mild stress (UCMS)-induced increase of central time and total travel distance. Mice were subjected to various
stressors in the presence or absence of the iNOS inhibitor 1400 W for 4 weeks. Central time and total travel distance were recorded for 5 minutes:
(A) central time; (B) total travel distance. Data are mean±SEM (n=10 for control; n=10 for stress; n=9 for stress+1400 W).
*P <0.05,
**P <0.01
compared to control.
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http://www.jneuroinflammation.com/content/9/1/75of NO production, are prominently higher in depressed
patients [33]. Additionally, some antidepressants inhibit
the enzymatic activity of NOS in animals and humans
[34,35]. The above facts implied a possible involvement of
NO in depression. In the past few years, several groups
have consistently reported that nNOS indeed plays a cru-
cial role in depression. The evidence for nNOS involve-
ment in depression includes nNOS expression increasing
in the hippocampus [36] and nNOS inhibition preventing
and reversing depressive-like behaviors [37,38]. Recently,
Wang et al. reported that iNOS also made contributions
to the mechanism of depression by using intrahippocam-
pal injections of the iNOS inhibitor aminoguanidine [39].
This research did not explore whether systemic injection
of iNOS inhibitor has the similar effect on depressive-like
behavior, and how the iNOS inhibitor functions, which is
our focus in this study. Mice were treated with UCMS for
4 weeks consecutively in the presence or absence of the
specific iNOS inhibitor 1400 W. The results showed that
treatment of mice with the iNOS inhibitor 1400 W pre-
vented the decrease of sucrose preference (P<0.05), the
increase of immobility time in FST (P<0.01), and the
Figure 8 Unpredictable chronic mild stress (UCMS) and inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)
acetamidine (1400 W) had no effect on resting time and number of activities. Mice were subjected to various stressors in the presence or
absence of the iNOS inhibitor 1400 W for 4 weeks. (A) Resting time; (B) number of activities. No significant difference was noted for each
comparison. Data are mean±SEM (n=10 for control; n=10 for stress; n=9 for stress+1400 W).
Figure 9 The specific inducible nitric oxide synthase (iNOS) inhibitor N-(3-(aminomethyl)benzyl)acetamidine (1400 W) protected
neurons from unpredictable chronic mild stress (UCMS)-induced damage. Mice were subjected to various stressors in the presence or
absence of the iNOS inhibitor 1400 W for 4 weeks. Undamaged neurons in the cerebral cortex were measured by Nissl staining. (A,B)
Representative slides of Nissl staining at two different magnifications ((A)×10, (B)×40). In the control group and stress plus 1400 W group,
neurons with round cell bodies, visible nucleus and abundant Nissl bodies were observed, while in stress group, Nissl-positive cells with dark
staining in which the nucleus were not discernable were obviously increased. (C) Cell counts. The number of undamaged cells in the stress group
was significantly lower than that of the control group and stress+1400 W group. Data are mean±SEM (n=3 in each group).
**P <0.01 for each
comparison.
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http://www.jneuroinflammation.com/content/9/1/75decrease of exploring time in the locomotor activity test
(P<0.01) induced by UCMS. These actions are specific to
depressive-like behavior and have no effect on locomotor
activity such as active time and resting time, which reflects
sickness behavior.
In accordance with the change of depressive-like be-
havior, the iNOS inhibitor 1400 W exhibited a significant
protection on neurons compared with UCMS group
(P<0.01). UCMS caused the loss of Nissl bodies in the
cerebral cortex neurons, and 1400 W pretreatment pre-
vented this loss. Namely, blocking NO abrogated neur-
onal damage caused by UCMS. This protection by
1400 W might be related to neuronal functional impair-
ment and structural damage caused by excessive NO. In
fact, stress-related events including depression are char-
acterized by modifications of oxidative/nitrosative path-
ways in the brain in response to the activation of
inflammatory mediators [1]. It has been shown that
repeated and unpredictable stress situations increase gen-
eration of reactive oxygen species (ROS) in the brain,
which in turn results in oxidative damage in the central
nervous system [40,41]. Recent findings indicate a key
role for NO and an excess of pro-oxidants in various
brain areas is responsible for both neuronal functional
impairment and structural damage [42]. Nevertheless, the
effects of oxidative stress in this present system require
further study, such as the measurement of some oxida-
tive/antioxidative parameters.
Over the last two to three decades, inflammatory depres-
sion has attracted increasing attention in the field of depres-
sion [43,44]. The main theory of inflammatory depression is
that the activation of the inflammatory immune system
may influence neurochemicals or damage neurons and
contribute to depression [45]. Under physiological condi-
tions, these proinflammatory cytokines enhance neurogen-
esis. However, excessive or prolonged cytokine exposure
may damage the brain (including affecting the metabolism
of neurotransmitter and neuropeptide, neuroendocrine and
neural plasticity, decreasing neurogenesis, increasing gluta-
matergic activation, oxidative stress, and induction of apop-
tosis) [46-50]. Chronic inflammation is often associated
with clinical depression [51-53]. Chronic stress dysregulates
immunity by overactivating the immune system, leading
to low-grade inflammation. iNOS is inflammation indu-
cible. Therefore, we conclude that iNOS may play an im-
portant role in the depressive behavior induced by
chronic stress exposure. Based on our experimental
results, chronic stress leads to a prominent increase of
inflammatory mediators (data not shown), which is con-
sistent with reports from other groups [42,54,55]. These
results support the notion that stress-related NO (derived
from iNOS) may contribute to depressive-like behavior in
a mouse model, potentially concurrent with neurodegen-
erative effects within the cerebral cortex. A dose course
is recommended in future studies to further establish the
rationale between UCMS-related depressive behavior and
iNOS/NO. Additionally, complete measurement of the
alteration of iNOS in individual brain regions is also
suggested, so that the key regions related to UCMS-
induced depression based on iNOS/NO can be identified
and located.
Conclusions
In summary, the present study supports the notion that
stress-related NO (derived from iNOS) may contribute
to depressive-like behavior in a mouse model, potentially
concurrent with neurodegenerative effects within the
cerebral cortex. These studies provide new insights into
the mechanisms underlying the responses of depression
to UCMS. A better understanding of the role of key sig-
naling mediators in depression could aid the develop-
ment of novel pharmacological agents. Further studies
on detailed and in-depth molecular mechanisms of
iNOS in UCMS-induced depressive-like behavior are
recommended.
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